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Introduction: Streptococcus pneumoniae is an uncommon etiologic agent in soft-tissue infections.
Case presentation: We report the case of a 35-year-old Caucasian woman who presented to our facility with
puerperal pneumococcal mastitis, and review the only other three cases of pneumococcal mastitis described in the
medical literature.
Conclusions: The roles of the various pneumococcal vaccines in preventing this disease are discussed.
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Puerperal mastitis occurs most commonly during the first
three to six months post-partum in breastfeeding mothers.
Up to 25 percent of breastfeeding women have experienced
at least one episode of mastitis, and recurrent mastitis has
been reported in four to eight-and-a-half percent of
breastfeeding women [1]. The most common causative or-
ganism of mastitis is Staphylococcus aureus. Other less com-
mon organisms include coagulase-negative staphylococci,
beta-hemolytic streptococci (Lancefield groups A or B),
Escherichia coli, and Corynebacterium species [2]. Strepto-
coccus pneumoniae is an extremely rare cause of mastitis. In
this paper, we present the case of a healthy 35-year-old
woman who presented to our facility with puerperal
pneumococcal mastitis, and review the only three other
cases of pneumococcal mastitis described in the medical
literature.
A literature review using a MEDLINE search from 1950
to July 2010 revealed only two cases of puerperal mastitis
and one case of non-puerperal mastitis caused by S.
pneumoniae (Table 1). The first case of pneumococcal
mastitis was described by DiNubile et al. in 1991 in a
23-year-old woman with systemic lupus erythematosus
who was being treated with prednisone but was not lactat-
ing [3]. She presented with an abscess of the left breast
and the aspirate revealed S. pneumoniae and Bacteroides* Correspondence: mmiller@jgh.mcgill.ca
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was in a healthy 38-year-old woman breastfeeding her
nine-month-old daughter [4]. In that case, serotyping was
performed on a nasal and throat swab taken from the
child as well as from the breast. All three cultures revealed
S. pneumoniae serotype 6B, which the authors reported as
being the second most frequent type found in the region
at that time. The third case was published by Kragsbjerg
et al. in 1995, concerning a 38-year-old woman who
presented with purulent secretions from the breast while
she was breastfeeding her four-month-old child [5].
Cultures taken from the breast and from the nasopharynx
of the child revealed the same serotype of S. pneumoniae.
Case presentation
A 35-year-old Caucasian woman who was breastfeeding
her eight-month-old twins presented to our facility with
a three-day history of fronto-parietal headache, fever,
general malaise, and two episodes of syncope on the day
of admission. On further questioning, she also reported
increasing pain in her right breast over the last 24 hours.
She appeared toxic and was febrile (39.0°C axillary
temperature). A physical examination revealed an ex-
quisitely tender right breast that was erythematous and
indurated in the right lower lateral quadrant. There was,
however, no area of fluctuance although purulent milky
secretions could be expelled from the right nipple with
mild peri-areolar pressure. These secretions were cul-
tured. Slightly tender right axillary adenopathy was also
present.Med Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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markable, including a normal blood count, except for
the presence of a left shift with 80 percent neutrophils
(total white blood cell count of 9.8×109 cells/L). Several
diagnostic investigations were performed, including a
lumbar puncture, cerebral computed tomography (CT)
and magnetic resonance imaging (MRI) scans, and blood
cultures, all of which yielded normal results. A clinical
diagnosis of puerperal mastitis was made, and treatment
with intravenous vancomycin and cefazolin was initiated.
Our patient continued pumping her breast milk. On the
day after admission, increased amounts of pus were
noted draining from the right nipple with each breast
pumping. Our patient’s fever and rigors resolved within
48 hours. Culture of the breast secretions at the time of
admission revealed heavy pure growth of S. pneumoniae,
polysaccharide serotype 19A, which was susceptible to
penicillin, cephalosporins, macrolides, tetracyclines and
vancomycin. Her hospital course was uncomplicated and
she was discharged home on day three post-admission
with a 10-day course of oral cefadroxil. Neither of her ba-
bies showed any evidence of a respiratory tract infection
prior to our patient’s illness; nasopharyngeal culture tests
from the babies were not performed as they were at home
with the father and unavailable for culture sampling.
Discussion
Pneumococcal mastitis is an extremely rare entity and, to
the best of our knowledge, there have been only three
other case reports in the literature, two of which were
puerperal. S. pneumoniae is a leading cause of respiratory
tract infections and meningitis in both children and
adults. It is, however, a rare cause of skin and soft-tissue
infections and the cases reported are mostly described in
patients who have some degree of immunosuppression
[6]. Our patient, whose case we present here, was a
healthy 35-year-old immunocompetent woman and therewere no signs of any connective tissue diseases or other
coincidental health issues.
Although neither of her babies showed any evidence
of a respiratory tract infection prior to our patient’s
illness, and testing of the babies was not undertaken due
to their unavailability, it appears that the most probable
way in which the mother became infected with S.
pneumoniae serotype 19A was from one or both of the
nasopharyngeal tracts of the babies during breastfeeding.
In both of the previous case reports [4,5], the breastfed
babies had tested positive on nasopharyngeal swabs and
showed symptoms of mild respiratory tract infections,
which is consistent with our interpretation of the mode
of transmission of the S. pneumoniae in mastitis. Our
patient's twin babies were both routinely vaccinated at
two and four months of age with Prevnar-7W (Wyeth,
Collegeville, PA, USA), which contains capsular antigens
of S. pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and
23F. Thus, the serotype 19A S. pneumoniae isolated in
our patient was not part of the seven-valent pneumococ-
cal conjugate vaccine administered to children in the
province of Quebec, where our patient resided at the
time of her illness. Current Quebec immunization guide-
lines recommend vaccination of healthy babies with a
pneumococcal seven-valent conjugate vaccine (Prevnar-
7W) to be given in three doses administered at two, four
and 12 months of age [7]. However, since the introduction
of Prevnar-7W, there has been growing concern of the de-
velopment and spread of the pneumococcal serotypes not
covered in the vaccine. A recent review by Reinert et al.
describes global indicators showing that serotype 19A is
now the most prevalent as well as the most increasingly
resistant S. pneumoniae serotype in invasive infections
[8]. The most prevalent serotypes involved in invasive
disease in Canada at the time of our patient’s presenta-
tion were (in descending order): 19A, 7F, 18C, 6A, 22F,
4, 5, 3 and 23B [9].
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(Prevnar-13W) that has recently been licensed in Canada,
will likely reduce the increasingly prevalent infection
rate from the 19A strain of S. pneumoniae. This new
vaccine contains the same antigens as Prevnar-7W with
six additional capsular antigens of serotypes 1, 3, 5, 6A,
7F and 19A [10], which together comprise 13 of the 91
S. pneumoniae serotypes described thus far [8].
Conclusions
This case report highlights the fact that puerperal mas-
titis may be caused by unusual bacteria, including S.
pneumoniae. Immunization of babies with effective
pneumococcal vaccines should decrease the incidence of
pneumococcal puerperal infections even further, as well
as other invasive pneumococcal infections that may be
similarly transmitted from baby to mother.
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